Johnson Johnson Company Executives
JNJ Stock | 21.56 0.11 0.51% |
Johnson Johnson employs about 138.1 K people. The company is managed by 23 executives with a total tenure of roughly 322234 years, averaging almost 14010.0 years of service per executive, having 6004.35 employees per reported executive. Analysis of Johnson Johnson's management performance can provide insight into the firm performance.
Johnson |
Johnson Johnson Management Team Effectiveness
The company has return on total asset (ROA) of 0.084 % which means that it generated a profit of $0.084 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2089 %, meaning that it generated $0.2089 on every $100 dollars invested by stockholders. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Johnson Johnson's Non Currrent Assets Other are very stable compared to the past year. As of the 21st of July 2025, Intangible Assets is likely to grow to about 34.5 B, while Total Assets are likely to drop about 142.4 B.Johnson Johnson Quarterly Income Before Tax |
|
Johnson Johnson Workforce Comparison
Johnson Johnson CDR is currently regarded as number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - General industry is currently estimated at about 168,589. Johnson Johnson totals roughly 138,100 in number of employees claiming about 82% of equities under Drug Manufacturers - General industry.
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25. Johnson Johnson CDR Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Johnson Johnson CDR Price Series Summation is a cross summation of Johnson Johnson price series and its benchmark/peer.
Johnson Johnson Notable Stakeholders
A Johnson Johnson stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Johnson Johnson often face trade-offs trying to please all of them. Johnson Johnson's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Johnson Johnson's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Joaquin Duato | CEO Chairman | Profile | |
Joseph CPA | Executive CFO | Profile | |
Dirk Brinckman | Chief Officer | Profile | |
Robert Decker | Controller Officer | Profile | |
Timothy Schmid | Executive MedTech | Profile | |
Elizabeth JD | Executive Officer | Profile | |
Tom Cavanaugh | Company Medicine | Profile | |
Kathryn Wengel | Executive Officer | Profile | |
James Swanson | Executive Officer | Profile | |
Michael Bodner | Global Recovery | Profile | |
Jennifer Taubert | Executive Medicine | Profile | |
Neil Davie | Hypertension Pulmonary | Profile | |
Mark Larkins | Worldwide Secretary | Profile | |
Jessica Moore | Vice Relations | Profile | |
Kristen Mulholland | Executive Officer | Profile | |
Susan MD | Vice Officer | Profile | |
Bill Martin | Global Companies | Profile | |
Vanessa Broadhurst | Executive Affairs | Profile | |
Hani Abouhalka | Company Digital | Profile | |
Ahmet Tezel | Group RD | Profile | |
Guy MD | Group EMEA | Profile | |
David Lee | Immunology Head | Profile | |
Penny MD | Office Head | Profile |
About Johnson Johnson Management Performance
The success or failure of an entity such as Johnson Johnson CDR often depends on how effective the management is. Johnson Johnson management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Johnson management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Johnson management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Johnson Johnson is entity of Canada. It is traded as Stock on NEO exchange.
Johnson Johnson Workforce Analysis
Traditionally, organizations such as Johnson Johnson use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Johnson Johnson within its industry.Johnson Johnson Manpower Efficiency
Return on Johnson Johnson Manpower
Revenue Per Employee | 616.6K | |
Revenue Per Executive | 3.7B | |
Net Income Per Employee | 254.5K | |
Net Income Per Executive | 1.5B | |
Working Capital Per Employee | 52.2K | |
Working Capital Per Executive | 313.6M |
Other Information on Investing in Johnson Stock
Johnson Johnson financial ratios help investors to determine whether Johnson Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Johnson with respect to the benefits of owning Johnson Johnson security.